DNA vaccine-encapsulated virus-like particles derived from an orally transmissible virus stimulate mucosal and systemic immune responses by oral administration (original) (raw)
Hoffmann C et al. Efficient gene transfer into human hepatocytes by baculovirus vectors. Proc Natl Acad Sci USA 1995; 92: 10099–10103. Article Google Scholar
Mistry AR et al. Recombinant HMG1 protein produced in Pichia pastoris: a nonviral gene delivery agent. Biotechniques 1997; 22: 718–729. ArticleCASPubMed Google Scholar
Afione A, Conrad CK, Flotte TR . Gene therapy vectors as drug delivery systems. Clin Pharmacokinet 1995; 28: 181–189. ArticleCASPubMed Google Scholar
Morrow CD et al. Recombinant viruses as vectors for mucosal immunity. In: Kraehenbuhl JP, Neutra MR (eds). Defense of Mucosal Surfaces: Pathogenesis, Immunity and Vaccines. Current Topics in Microbiology and Immunology, Vol. 236 Springer-Verlag: Berlin, 1999, pp 255–273. Chapter Google Scholar
Medina E, Guzman CA . Modulation of immune responses following antigen administration by mucosal route. FEMS Immunol Med Microbiol 2000; 27: 305–311. ArticleCASPubMed Google Scholar
Ulrich R, Nassal M, Meisel H, Kruger DH . Core particles of hepatitis B virus as carrier for foreign epitopes. Adv Virus Res 1998; 50: 141–182. ArticleCASPubMed Google Scholar
Clark B et al. Immunity against both polyomavirus VP1 and a transgene product following intranasal delivery of VP1 pseudocapsid–DNA complexes. J Gen Virol 2001; 82: 2791–2797. ArticleCASPubMed Google Scholar
Li TC et al. Expression and self-assembly of empty virus-like particles of hepatitis E virus. J Virol 1997; 71: 7207–7213. CASPubMedPubMed Central Google Scholar
Niikura M et al. Chimeric recombinant hepatitis E virus-like particles as an oral vaccine vehicle presenting foreign epitopes. Virology 2002; 293: 273–280. ArticleCASPubMed Google Scholar
Etchart N et al. Class-I restricted CTL induction by mucosal immunization with naked DNA encoding measles virus haemagglutinin. J Gen Virol 1997; 78: 1577–1580. ArticleCASPubMed Google Scholar
Feltquate DM, Heaney S, Webster RG, Robinson HL . Different T helper cell types and antibody isotypes generated by saline and gene gun DNA immunization. J Immunol 1997; 158: 2278–2284. CASPubMed Google Scholar
McCluskie MJ et al. Direct gene transfer to the respiratory tract of mice with pure plasmid and lipid formulated DNA. Antisense Nucleic Acid Drug Dev 1998; 8: 401–414. ArticleCASPubMed Google Scholar
Kaneko H et al. Oral DNA vaccination promotes mucosal and systemic immune responses to HIV envelope glycoprotein. Virology 2000; 267: 8–16. ArticleCASPubMed Google Scholar
Chen SC et al. Protective immunity induced by oral immunization with a rotavirus DNA vaccine encapsulated in microparticles. J Virol 1998; 72: 5757–5761. CASPubMedPubMed Central Google Scholar
Eldridge JH et al. Controlled vaccine release in the gut-associated lymphoid tissues. I. Orally administered biodegradable microspheres target the Payer's patches. J Control Rel 1990; 11: 205–214. ArticleCAS Google Scholar
Condon C et al. DNA-based immunization by in vivo transfection of dendriric cells. Nat Med 1996; 10: 1122–1128. Article Google Scholar
Li TC et al. Oral administration of hepatitis E virus-like particles induces a systemic and mucosal immune response in mice. Vaccine 2001; 14: 3476–3484. Article Google Scholar
Worm HC, van der Poel WHM, Brandstartter G . Hepatitis E: an overview. Microbes Inf 2002; 4: 657–666. ArticleCAS Google Scholar
Nahde T et al. Combined transductional and transcriptional targeting of melanoma cerlls by artificial virus-like particles. J Gene Med 2001; 3: 353–361. ArticleCASPubMed Google Scholar
Nagaraj K, Babu BV . Field trials of oral cholera vaccine in Vietnam. Lancet 1997; 349: 1253–1254. ArticleCASPubMed Google Scholar
Ball JM et al. Recombinant Norwalk virus-like particles given orally to volunteers: phase I study. Gastroenterology 1999; 117: 40–48. ArticleCASPubMed Google Scholar
Promoting the free-flow of information within the DNA vaccine community URL: http://dnavaccine.com.
Takahashi H et al. An immunodominant epitope of the human immunodeficiency virus envelope glycoprotein gp160 recognized by class I major histocompatibility complex molecule-restricted murine cytotoxic T lymphocytes. Proc Natl Acad Sci USA 1988; 85: 3105–3109. ArticleCASPubMedPubMed Central Google Scholar
Shirai M et al. Induction of cytotoxic T cells a cross-reactive epitope in the hepatitis C virus nonstructural RNA polymerase-like protein. J Virol 1992; 66: 4908–4106.
Yasutomi Y et al. Simian immunodeficiency virus-specific cytotoxic T lymphocyte induction through DNA vaccination of rhesus monkeys. J Virol 1996; 70: 678–681. CASPubMedPubMed Central Google Scholar
Adachi A et al. Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J Virol 1986; 59: 284–291. CASPubMedPubMed Central Google Scholar
Picnus SH, Wehrly K, Chesebro B . Treatment of HIV tissue culture infection with monoclonal antibody–ricin A chain conjugate. J Immunol 1998; 142: 3070–3075. Google Scholar
Toriyoshi H et al. Sendai virus-based production of HIV type 1 subtype B and subtype E envelope glycoprotein 120 antigens and their use for highly sensitive detection of subtype-specific serum antibodies. AIDS Res Hum Retroviruses 1999; 15: 1109–1120. ArticleCASPubMed Google Scholar